These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 7249373)

  • 1. Deficiency of fumarylacetoacetase in a patient with hereditary tyrosinemia.
    Berger R; Smit GP; Stoker-de Vries SA; Duran M; Ketting D; Wadman SK
    Clin Chim Acta; 1981 Jul; 114(1):37-44. PubMed ID: 7249373
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urinary excretion of succinylacetone and delta-aminolevulinic acid in patients with hereditary tyrosinemia.
    Christensen E; Jacobsen BB; Gregersen N; Hjeds H; Pedersen JB; Brandt NJ; Baekmark UB
    Clin Chim Acta; 1981 Nov; 116(3):331-41. PubMed ID: 7296896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assay of fumarylacetoacetate fumarylhydrolase in human liver-deficient activity in a case of hereditary tyrosinemia.
    Kvittingen EA; Jellum E; Stokke O
    Clin Chim Acta; 1981 Sep; 115(3):311-9. PubMed ID: 7296877
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urinary excretion of deuterated metabolites in patients with tyrosinemia type I after oral loading with deuterated L-tyrosine.
    Wadman SK; Duran M; Ketting D; Bruinvis L; van Sprang FJ; Berger R; Smit GP; Steinmann B; Leonard JV; Divry P; Farriaux JP; Cartigny B
    Clin Chim Acta; 1983 May; 130(2):231-8. PubMed ID: 6872257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The pre- and post-natal diagnosis of tyrosinemia type I and the detection of the carrier state by assay of fumarylacetoacetase.
    Kvittingen EA; Brodtkorb E
    Scand J Clin Lab Invest Suppl; 1986; 184():35-40. PubMed ID: 3473612
    [TBL] [Abstract][Full Text] [Related]  

  • 6. On the enzymic defects in hereditary tyrosinemia.
    Lindblad B; Lindstedt S; Steen G
    Proc Natl Acad Sci U S A; 1977 Oct; 74(10):4641-5. PubMed ID: 270706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hereditary tyrosinemia type I--an overview.
    Kvittingen EA
    Scand J Clin Lab Invest Suppl; 1986; 184():27-34. PubMed ID: 3296130
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Type I tyrosinemia: lack of immunologically detectable fumarylacetoacetase enzyme protein in tissues and cell extracts.
    Berger R; Van Faassen H; Taanman JW; De Vries H; Agsteribbe E
    Pediatr Res; 1987 Oct; 22(4):394-8. PubMed ID: 3317254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hereditary tyrosinemia type I: lack of correlation between clinical findings and amount of immunoreactive fumarylacetoacetase protein.
    Kvittingen EA; Rootwelt H; van Dam T; van Faassen H; Berger R
    Pediatr Res; 1992 Jan; 31(1):43-6. PubMed ID: 1594329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biochemical studies on the enzymatic deficiencies in hereditary tyrosinemia.
    Berger R; van Faassen H; Smith GP
    Clin Chim Acta; 1983 Oct; 134(1-2):129-41. PubMed ID: 6652907
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deficient fumarylacetoacetate fumarylhydrolase activity in lymphocytes and fibroblasts from patients with hereditary tyrosinemia.
    Kvittingen EA; Halvorsen S; Jellum E
    Pediatr Res; 1983 Jul; 17(7):541-4. PubMed ID: 6622096
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hereditary tyrosinemia type I. Self-induced correction of the fumarylacetoacetase defect.
    Kvittingen EA; Rootwelt H; Brandtzaeg P; Bergan A; Berger R
    J Clin Invest; 1993 Apr; 91(4):1816-21. PubMed ID: 8473520
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genotyping of a case of tyrosinaemia type I with normal level of succinylacetone in amniotic fluid.
    Poudrier J; Lettre F; St-Louis M; Tanguay RM
    Prenat Diagn; 1999 Jan; 19(1):61-3. PubMed ID: 10073910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impaired synthesis of taurine in a patient with tyrosinemia type I during the oral L-methionine loading test.
    Valík D; Klusácek D; Pintera J
    Clin Chim Acta; 1992 Sep; 210(3):227-9. PubMed ID: 1468144
    [No Abstract]   [Full Text] [Related]  

  • 15. Prenatal diagnosis of hereditary tyrosinemia by determination of fumarylacetoacetase in cultured amniotic fluid cells.
    Kvittingen EA; Steinmann B; Gitzelmann R; Leonard JV; Andria G; Børresen AL; Mossman J; Micara G; Lindblad B
    Pediatr Res; 1985 Apr; 19(4):334-7. PubMed ID: 4000758
    [TBL] [Abstract][Full Text] [Related]  

  • 16. On the renal tubular damage in hereditary tyrosinemia and on the formation of succinylacetoacetate and succinylacetone.
    Fällström SP; Lindblad B; Steen G
    Acta Paediatr Scand; 1981; 70(3):315-20. PubMed ID: 7246125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hereditary tyrosinemia and the heme biosynthetic pathway. Profound inhibition of delta-aminolevulinic acid dehydratase activity by succinylacetone.
    Sassa S; Kappas A
    J Clin Invest; 1983 Mar; 71(3):625-34. PubMed ID: 6826727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The human fumarylacetoacetase gene: characterisation of restriction fragment length polymorphisms and identification of haplotypes in tyrosinemia type 1 and pseudodeficiency.
    Rootwelt H; Kvittingen EA; Høie K; Agsteribbe E; Hartog M; van Faassen H; Berger R
    Hum Genet; 1992 May; 89(2):229-33. PubMed ID: 1350265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hereditary tyrosinemia. Formation of succinylacetone-amino acid adducts.
    Manabe S; Sassa S; Kappas A
    J Exp Med; 1985 Sep; 162(3):1060-74. PubMed ID: 3928801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Concentrations of succinylacetone after homogentisate and tyrosine loading in healthy individuals with low fumarylacetoacetase activity.
    Kvittingen EA; Leonard JV; Pettit BR; King GS
    Clin Chim Acta; 1985 Nov; 152(3):271-9. PubMed ID: 4064334
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.